National Health Investors, Inc. $NHI Holdings Raised by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL grew its stake in shares of National Health Investors, Inc. (NYSE:NHI) by 189.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 116,570 shares of the real estate investment trust’s stock after buying an additional 76,339 shares during the quarter. Tudor Investment Corp ET AL owned about 0.24% of National Health Investors worth $9,267,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also made changes to their positions in NHI. Cambria Investment Management L.P. lifted its position in National Health Investors by 15.6% in the third quarter. Cambria Investment Management L.P. now owns 8,190 shares of the real estate investment trust’s stock worth $651,000 after purchasing an additional 1,105 shares during the period. CIBC Bancorp USA Inc. bought a new position in shares of National Health Investors during the 3rd quarter valued at about $392,000. Advisory Services Network LLC acquired a new position in shares of National Health Investors in the 3rd quarter worth approximately $65,000. NewEdge Advisors LLC boosted its holdings in National Health Investors by 134.6% during the third quarter. NewEdge Advisors LLC now owns 4,822 shares of the real estate investment trust’s stock worth $383,000 after buying an additional 2,767 shares in the last quarter. Finally, CANADA LIFE ASSURANCE Co grew its position in National Health Investors by 5.7% in the third quarter. CANADA LIFE ASSURANCE Co now owns 88,396 shares of the real estate investment trust’s stock worth $6,948,000 after buying an additional 4,760 shares during the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Stock Down 3.7%

NHI stock opened at $81.65 on Monday. The company has a 50 day moving average of $84.20 and a two-hundred day moving average of $79.65. The company has a market cap of $3.96 billion, a price-to-earnings ratio of 27.04, a PEG ratio of 4.44 and a beta of 0.65. National Health Investors, Inc. has a 12-month low of $66.41 and a 12-month high of $91.38. The company has a quick ratio of 6.90, a current ratio of 6.90 and a debt-to-equity ratio of 0.76.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.01). National Health Investors had a return on equity of 9.56% and a net margin of 37.81%.The company had revenue of $105.82 million during the quarter, compared to analyst estimates of $95.12 million. During the same period last year, the company posted $1.24 earnings per share. The company’s revenue was up 6.8% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. On average, equities analysts anticipate that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Tuesday, March 31st will be given a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a yield of 4.5%. The ex-dividend date of this dividend is Tuesday, March 31st. National Health Investors’s dividend payout ratio (DPR) is presently 121.85%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on NHI. National Bank Financial set a $85.00 price target on National Health Investors in a research report on Tuesday, January 20th. Deutsche Bank Aktiengesellschaft downgraded shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price target for the company. in a research report on Tuesday, January 20th. Wells Fargo & Company lifted their price objective on shares of National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 25th. Truist Financial increased their target price on National Health Investors from $85.00 to $92.00 and gave the company a “buy” rating in a report on Thursday, March 12th. Finally, Cantor Fitzgerald set a $85.00 price target on National Health Investors in a report on Monday, January 5th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $86.67.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.